DGFT relaxes pharma export curbs

March 21, 2020 10:40 pm | Updated 10:40 pm IST - HYDERABAD

The Centre has relaxed the export restrictions it had introduced earlier this month on 13 active pharmaceutical ingredients (APIs) and an equal number of formulations made from them.

In a notification, the Directorate General of Foreign Trade (DGFT) said all the formulations in the March 3 notification will be permitted for export under the advance licences issued on or before the date of notification. However, no enhancement of quantity will be permittedfor import and export items in these Advance Licences.

Another notification said as per SEZ Rules, the restrictions on exports do not apply to SEZs. “It is therefore clarified that the exports of restricted APIs and formulations made from these APIs is allowed from SEZ units,” it said.

The changes follow representations from exporters highlighting issues faced by them in fulfilling export obligations under Advance Authorization scheme as well as from SEZ units, the DGFT said.

Close on the heels of the March 3 notification, Pharmaceuticals Export Promotion Council of India Director General Ravi Uday Bhaskar had pointed out how for exporters the restrictions will be a problem and bound to impact their reputation. The restrictions were bound to come in the way of the commitments made and not complying with them may result in complications for exporters, he had said. Pharmexcil had also represented the matter to the DGFT, seeking relaxation of the restrictions for shipments lying at ports.

Figuring in the list of 26 items were common fever medicine paracetamol and several antibiotics, Vitamin B1, B6 and B12 as well as formulations made from them.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.